• Cardiol Therapeutics (NASDAQ:CRDL) Earns Buy Rating from Analysts at Rodman & Renshaw

    المصدر: Buzz FX / 28 يناير 2025 06:41:19   America/Chicago


    Cardiol Therapeutics (NASDAQ:CRDL) Earns Buy Rating from Analysts at Rodman & Renshaw Written by MarketBeat January 28, 2025 Share Link copied to clipboard. Equities researchers at Rodman & Renshaw started coverage on shares of Cardiol Ther
    Read more...
شارك على،